Viewing Study NCT06412458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:15 AM
Ignite Modification Date: 2026-02-01 @ 12:56 PM
Study NCT ID: NCT06412458
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-14
First Post: 2024-04-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Osteosarcoma View
None Recurrent Osteosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IM83 CAR-T View
None Relapsed or refractory osteosarcoma View